Literature DB >> 8462382

Exaggerated hyperglycemia after a pizza meal in well-controlled diabetes.

J A Ahern1, P M Gatcomb, N A Held, W A Petit, W V Tamborlane.   

Abstract

OBJECTIVE: To examine whether the postprandial hyperglycemic effect of pizza in well-controlled IDDM patients is related to overeating or to unique properties of this popular food. RESEARCH DESIGN AND METHODS: On two evenings, each patient (n = 8) consumed a meal that was similar in macronutrient composition except that one consisted of pizza and the other was a control meal that included high glycemic index foods. The insulin regimen was held constant.
RESULTS: Postprandial glucose levels were within the target range (< or = 10 mM) after the control meal. Although the initial glucose increase was similar for the two meals, plasma glucose continued to rise and was significantly increased from 4 to 9 h after ingestion of pizza compared with the control meal (P < 0.05). This increase occurred even though free insulin, glucagon, and free fatty acid levels did not differ significantly.
CONCLUSIONS: Our data suggest that pizza has properties that accentuate and sustain postprandial hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8462382     DOI: 10.2337/diacare.16.4.578

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  10 in total

1.  Misled by the Morning "Fasting" Plasma Glucose.

Authors:  Allen B King
Journal:  J Diabetes Sci Technol       Date:  2015-05-13

2.  Identification of intraday metabolic profiles during closed-loop glucose control in individuals with type 1 diabetes.

Authors:  Sami S Kanderian; Stu Weinzimer; Gayane Voskanyan; Garry M Steil
Journal:  J Diabetes Sci Technol       Date:  2009-09-01

Review 3.  New concepts in diabetes mellitus. I: Treatment, pregnancy and aetiology.

Authors:  R Taylor; M Vanderpump
Journal:  Postgrad Med J       Date:  1994-06       Impact factor: 2.401

4.  The effect of insulin feedback on closed loop glucose control.

Authors:  Garry M Steil; Cesar C Palerm; Natalie Kurtz; Gayane Voskanyan; Anirban Roy; Sachiko Paz; Fouad R Kandeel
Journal:  J Clin Endocrinol Metab       Date:  2011-03-02       Impact factor: 5.958

5.  Estimating insulin demand for protein-containing foods using the food insulin index.

Authors:  K J Bell; R Gray; D Munns; P Petocz; G Howard; S Colagiuri; J C Brand-Miller
Journal:  Eur J Clin Nutr       Date:  2014-07-09       Impact factor: 4.016

6.  Improving the estimation of mealtime insulin dose in adults with type 1 diabetes: the Normal Insulin Demand for Dose Adjustment (NIDDA) study.

Authors:  Jiansong Bao; Heather R Gilbertson; Robyn Gray; Diane Munns; Gabrielle Howard; Peter Petocz; Stephen Colagiuri; Jennie C Brand-Miller
Journal:  Diabetes Care       Date:  2011-10       Impact factor: 19.112

Review 7.  Carbohydrate Counting in Children and Adolescents with Type 1 Diabetes.

Authors:  Giorgia Tascini; Maria Giulia Berioli; Laura Cerquiglini; Elisa Santi; Giulia Mancini; Francesco Rogari; Giada Toni; Susanna Esposito
Journal:  Nutrients       Date:  2018-01-22       Impact factor: 5.717

8.  A higher blood glucose level pre-breakfast in comparison to bedtime is a contraindication for intensification of prandial insulin therapy in patients with type 2 diabetes - The impact of a negative BeAM value.

Authors:  Thorsten Siegmund; Anja Borck; Ariel Zisman; Peter Bramlage; Stephan Kress
Journal:  J Clin Transl Endocrinol       Date:  2018-10-23

9.  Dietary fat acutely increases glucose concentrations and insulin requirements in patients with type 1 diabetes: implications for carbohydrate-based bolus dose calculation and intensive diabetes management.

Authors:  Howard A Wolpert; Astrid Atakov-Castillo; Stephanie A Smith; Garry M Steil
Journal:  Diabetes Care       Date:  2012-11-27       Impact factor: 19.112

10.  Influence of dietary protein on postprandial blood glucose levels in individuals with Type 1 diabetes mellitus using intensive insulin therapy.

Authors:  M A Paterson; C E M Smart; P E Lopez; P McElduff; J Attia; C Morbey; B R King
Journal:  Diabet Med       Date:  2015-12-06       Impact factor: 4.359

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.